News: Brendan Jenkins

SAiGENCI recruit recognised with prestigious award

Professor Jenkins has been appointed as the Program Head for the Tumour Inflammation and Immunotherapy Program at the South Australian ImmunoGENomics Cancer Institute (SAiGENCI), which operates within the University of Adelaide’s Faculty of Health and Medical Sciences, and is supported by an alliance with the Central Adelaide Local Health Network (CALHN).

[Read more about SAiGENCI recruit recognised with prestigious award]